ADITXT INVESTOR ALERT - Kuznicki Law PLLC Investigates Adequacy of Price and Process in Proposed Sale of Aditxt, Inc. - ADTX
March 10 2022 - 5:28PM
Business Wire
Kuznicki Law PLLC is investigating the proposed sale of AiPharma
Group Ltd. to Aditxt, Inc. (“the Company”) (NasdaqCM: ADTX). Under
the terms of the proposed transaction, Aditxt will first acquire
9.5% of the issued and outstanding equity interests in AiPharma in
exchange for the issuance of approximately 4.8 million shares of
common stock of Aditxt and a cash payment of $250,000. Aditxt would
then acquire the remaining 90.5% of the issued and outstanding
equity interests in AiPharma in exchange for the issuance of
approximately 39.9 million shares of common stock of Aditxt and a
cash payment of $250,000 at a secondary closing. Kuznicki Law is
seeking to determine whether the merger and the process that led to
it are adequate and fair to the Company’s shareholders.
If you would like to discuss your legal rights regarding the
proposed sale, you may, without obligation or cost to you, contact
us toll free at 833-938-0905, via email (dk@kclasslaw.com), or
visit https://kclasslaw.com/cases/ma/nasdaqcm-adtx/ to learn
more.
Kuznicki Law PLLC is committed to ensuring that companies adhere
to responsible business practices and engage in good corporate
citizenship. The firm seeks recovery on behalf of investors who
incurred losses when false and/or misleading statements or the
omission of material information by a Company lead to artificial
inflation of the Company’s stock. Attorney advertising. Prior
results do not guarantee similar outcomes.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220310006014/en/
Kuznicki Law PLLC Daniel Kuznicki, Esq. Email: dk@kclasslaw.com
Phone: (347) 696-1134 Cell: (347) 690-0692 Fax: (347) 348-0967
https://kclasslaw.com
Aditxt (NASDAQ:ADTX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Aditxt (NASDAQ:ADTX)
Historical Stock Chart
From Sep 2023 to Sep 2024